{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-23-000012","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2023-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.591582+00:00","generated_at":"2026-06-18T22:30:35.193372+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Clover Health Q4 revenue $898.8M; Insurance MCR improves to 92.4% from 102.8% YoY","bullets":["Full year 2022 Insurance MCR improved to 91.8% from 106.0% in 2021, a 1,420 bps improvement.","Q4 net loss narrowed to $84.0M from $187.2M; Adjusted EBITDA loss improved to $81.1M from $87.4M.","2023 guidance: Insurance MCR 89%-91%, Non-Insurance MCR 98%-100%.","Consolidated cash and investments $555.3M; parent-level liquidity $331.7M expected to cover 2023 needs.","Non-Insurance MCR remained above 100% at 103.6% in Q4 and 103.4% for full year."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-23-000012","json":"https://secwatch.observer/filing/0001801170-23-000012.json","markdown":"https://secwatch.observer/filing/0001801170-23-000012.md","text":"https://secwatch.observer/filing/0001801170-23-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000012/0001801170-23-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000012/clov-20230228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T22:30:35.193372+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"48a4ae1fedb4ed4e5e6a21b020bcfaa329de9020","claim":"CLOVER HEALTH INVESTMENTS, CORP. /DE reported the fiscal year ended December 31, 2022 results: revenue $ 3,476.7, net income (338.8). Guidance initiated.","evidence_excerpt":"Total revenue $ 898.8 $ 432.0 $ 3,476.7 $ 1,472.0 Insurance MCR 92.4 % 102.8 % 91.8 % 106.0 % Non-Insurance MCR 103.6 103.0 103.4 105.7 Salaries and benefits plus General and administrative expenses (\"SG&A\") (1) $ 124.3 $ 114.1 $ 486.6 $ 445.7 Adjusted Salaries and benefits plus General and administrative expenses (\"Adjusted SG&A\") (non-GAAP) (1)(2)(3) 85.6 77.5 320.7 264.4 Net loss (84.0) (187.2) (338.8) (587.8)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000012/0001801170-23-000012-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2022"},{"label":"Revenue","value":"$ 3,476.7"},{"label":"Net income","value":"(338.8)"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"f545f67a07c524fb19195df606ae720fcd5f1e0b","claim":"CLOVER HEALTH INVESTMENTS, CORP. /DE reported the fourth quarter ended December 31, 2022 results: revenue $ 898.8, net income (84.0). Guidance initiated.","evidence_excerpt":"Total revenue $ 898.8 $ 432.0 $ 3,476.7 $ 1,472.0 Insurance MCR 92.4 % 102.8 % 91.8 % 106.0 % Non-Insurance MCR 103.6 103.0 103.4 105.7 Salaries and benefits plus General and administrative expenses (\"SG&A\") (1) $ 124.3 $ 114.1 $ 486.6 $ 445.7 Adjusted Salaries and benefits plus General and administrative expenses (\"Adjusted SG&A\") (non-GAAP) (1)(2)(3) 85.6 77.5 320.7 264.4 Net loss (84.0) (187.2) (338.8) (587.8)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000012/0001801170-23-000012-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$ 898.8"},{"label":"Net income","value":"(84.0)"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}